A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Amgen Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 299,818 shares of AMGN stock, worth $85.6 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
299,818
Previous 236,455 26.8%
Holding current value
$85.6 Million
Previous $73.9 Million 30.76%
% of portfolio
0.45%
Previous 0.36%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$309.38 - $337.38 $19.6 Million - $21.4 Million
63,363 Added 26.8%
299,818 $96.6 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $656,875 - $798,275
2,500 Added 1.07%
236,455 $73.9 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $277,473 - $334,945
-1,032 Reduced 0.44%
233,955 $66.5 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $11.8 Million - $13.3 Million
45,958 Added 24.31%
234,987 $67.7 Million
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $12.3 Million - $15.2 Million
56,169 Added 42.28%
189,029 $50.8 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $1.19 Million - $1.41 Million
5,575 Added 4.38%
132,860 $29.5 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $12.5 Million - $15.3 Million
-55,502 Reduced 30.36%
127,285 $30.8 Million
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $11.5 Million - $14.6 Million
50,197 Added 37.86%
182,787 $48 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $1.73 Million - $1.95 Million
-7,707 Reduced 5.49%
132,590 $29.9 Million
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $1.49 Million - $1.65 Million
-6,446 Reduced 4.39%
140,297 $34.1 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $3.94 Million - $4.36 Million
-17,983 Reduced 10.92%
146,743 $35.5 Million
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $17.8 Million - $20.4 Million
-89,696 Reduced 35.25%
164,726 $37.3 Million
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $18 Million - $21.1 Million
-84,778 Reduced 24.99%
254,422 $54.1 Million
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $43.3 Million - $48.1 Million
-185,509 Reduced 35.35%
339,200 $82.7 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $55.1 Million - $64.3 Million
-248,460 Reduced 32.14%
524,709 $131 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $14.9 Million - $17.7 Million
-68,803 Reduced 8.17%
773,169 $178 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $3.37 Million - $3.75 Million
-14,373 Reduced 1.68%
841,972 $214 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $14.5 Million - $17.8 Million
-73,240 Reduced 7.88%
856,345 $202 Million
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $663,900 - $880,513
3,643 Added 0.39%
929,585 $188 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $32.4 Million - $41.6 Million
170,985 Added 22.65%
925,942 $223 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $93.3 Million - $112 Million
535,829 Added 244.53%
754,957 $146 Million
Q2 2019

Aug 09, 2019

SELL
$166.7 - $195.41 $2.46 Million - $2.88 Million
-14,736 Reduced 6.3%
219,128 $40.4 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $4.42 Million - $4.99 Million
24,462 Added 11.68%
233,864 $44.4 Million
Q4 2018

Feb 12, 2019

SELL
$178.4 - $208.25 $8.53 Million - $9.96 Million
-47,836 Reduced 18.6%
209,402 $40.8 Million
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $30.3 Million - $34.1 Million
-163,476 Reduced 38.86%
257,238 $53.3 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $5.24 Million - $5.89 Million
31,570 Added 8.11%
420,714 $77.7 Million
Q1 2018

Apr 30, 2018

SELL
$169.43 - $198.0 $42 Million - $49.1 Million
-247,789 Reduced 38.9%
389,144 $66.3 Million
Q4 2017

Feb 12, 2018

SELL
$168.79 - $188.59 $3.28 Million - $3.67 Million
-19,452 Reduced 2.96%
636,933 $111 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $217,477 - $248,300
-1,300 Reduced 0.2%
656,385 $122 Million
Q2 2017

Aug 14, 2017

BUY
N/A
657,685
657,685 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $153B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.